The effect of radiofrequency on improvement of vaginalaxity and loss of sexuality in wome
- Conditions
- Vaginalaxity.Female genital prolapse
- Registration Number
- IRCT20201006048949N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Age between 25-50 years
Having complaints of vaginal laxity
Not having breastfed within the the three months before the study
Sexual activity (vaginal sex at least once a month)
Normal Pap test result
Negative pregnancy test before entering the study
Pelvic organ prolapse has exceeded the hymenal ring (grade 3 and 4 prolapse)
Active sexually transmitted disease (Condylomata acuminata / herpes)
Chronic vulvar pain or vulvar dystrophy
Using known medications that affect sexual function (antihypertensive and psychotropic drugs / chemotherapeutic agents)
Daily use of anti-inflammatory drugs which can affect collagen in healing (ibuprofen / aspirin / steroids)
Chronic skin disorder including vulvar involvement
Medical problem that interferes with wound healing.
Thin rectovaginal septum
Under treatment for Hypoactive Sexual Desire Disorder (HSDD) or orgasmic disorder
Irritable bowel syndrome (IBS)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sexual function. Timepoint: Before the intervention, at months 1, 2, 3 during the study before each treatment session, and 3and 6 months after the intervention. Method of measurement: Female Sexual Function Index.;Vaginal laxity. Timepoint: Before the intervention, at months 1, 2, 3 during the study before each treatment session, and 3and 6 months after the intervention. Method of measurement: Vaginal Laxity Questionnaire.
- Secondary Outcome Measures
Name Time Method